DBV Technologies SA (DBVT)
20.61
-0.64
(-3.01%)
USD |
NASDAQ |
Apr 16, 16:00
21.80
+1.19
(+5.77%)
Pre-Market: 09:07
DBV Technologies Cash from Investing (Quarterly) : -0.7165M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| EDAP TMS SA | -1.695M |
| Cellectis SA | 22.57M |
| Ascendis Pharma A/S | -3.872M |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.19M |
| Cash from Financing (Quarterly) | 159.43M |
| Free Cash Flow | -122.10M |
| Free Cash Flow Per Share (Quarterly) | -0.9287 |
| Free Cash Flow to Equity (Quarterly) | -41.26M |
| Free Cash Flow to Firm (Quarterly) | -35.57M |
| Free Cash Flow Yield | -20.95% |